Trial
NCT03003143
Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Seoul National University Hospital
Collaborators
—
Condition
Autoimmune Encephalopathy
Intervention
Vigabatrin 500 MG
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-09-29